causal
Analysis v1
61
Pro
0
Against

People with fatty liver disease on a low-calorie diet don’t lose muscle if they eat at least 0.8 grams of protein per kilogram of body weight each day — eating more protein doesn’t help any more.

Scientific Claim

In adults with metabolic dysfunction-associated steatotic liver disease (MASLD) undergoing 30% caloric restriction for 4 weeks, consuming 0.8 g·kg⁻¹·day⁻¹ of protein preserves skeletal muscle mass, but this preservation is not enhanced by increasing protein intake to 1.5 g·kg⁻¹·day⁻¹.

Original Statement

Across ~30% CR, all groups reduced body weight and fat mass without skeletal muscle mass loss; no between-group differences in body composition changes were observed.

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

definitive

Can make definitive causal claims

Assessment Explanation

The RCT design with controlled protein intake and direct measurement of muscle mass via BIA allows causal inference. The claim correctly states preservation occurred at 0.8 g/kg/day and no added benefit from 1.5 g/kg/day, matching the data.

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Systematic Review & Meta-Analysis
Level 1a

The minimum effective protein dose for muscle preservation in MASLD during caloric restriction across diverse populations.

What This Would Prove

The minimum effective protein dose for muscle preservation in MASLD during caloric restriction across diverse populations.

Ideal Study Design

A meta-analysis of RCTs comparing protein intakes of 0.6–1.8 g/kg/day in adults with MASLD (CAP ≥280 dB/m) undergoing 20–30% caloric restriction for 4–12 weeks, with primary outcome of change in fat-free mass via DXA or BIA, stratified by baseline BMI and sex.

Limitation: Cannot account for differences in protein timing, leucine content, or training status across studies.

Randomized Controlled Trial
Level 1b
In Evidence

Causal effect of protein dose (0.8 vs. 1.5 g/kg/day) on muscle mass preservation in MASLD under caloric restriction.

What This Would Prove

Causal effect of protein dose (0.8 vs. 1.5 g/kg/day) on muscle mass preservation in MASLD under caloric restriction.

Ideal Study Design

A double-blind, parallel-group RCT with 120+ adults with MASLD (BMI 25–35, CAP ≥280 dB/m), randomized to 0.8, 1.2, or 1.5 g/kg/day protein under 30% caloric restriction for 8 weeks, with primary outcome of fat-free mass change via DXA, secondary outcomes of muscle protein synthesis rates via stable isotope tracing.

Limitation: Cannot determine if effects persist beyond 8 weeks or in more severe obesity.

Prospective Cohort Study
Level 2b

Long-term association between habitual protein intake and muscle mass retention in MASLD during weight loss.

What This Would Prove

Long-term association between habitual protein intake and muscle mass retention in MASLD during weight loss.

Ideal Study Design

A 1-year prospective cohort of 150+ adults with MASLD undergoing weight loss, tracking daily protein intake via food diaries and measuring fat-free mass via DXA every 3 months, adjusting for energy deficit, physical activity, and liver enzyme changes.

Limitation: Cannot establish causation due to observational design and potential dietary reporting bias.

Evidence from Studies

Supporting (1)

61

In people with fatty liver who eat less food, eating more protein didn’t help them keep more muscle than eating the standard amount — so the extra protein didn’t make a difference.

Contradicting (0)

0
No contradicting evidence found